Managing COVID-19 in OBGYN and MFM settings

Clinical Bulletins

Critical Summary

  • Pregnant women may be at greater risk from complications should they acquire COVID-19, caused by the enveloped virus SARS-CoV-2.
  • SARS-CoV-2 can survive on surfaces for days, and one study has reported survival in aerosols for >3 hours.
  • It is imperative infection prevention efforts are maximised in the OB/GYN and MFM setting to mitigate transmission risk to pregnant patients.
  • Guidance from professional societies provide advice on infection prevention strategies, including ultrasound equipment disinfection, to minimize infection risks.